Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
Pleyer L, Leisch M, Kourakli A, Padron E, Maciejewski JP, Xicoy Cirici B, Kaivers J, Ungerstedt J, Heibl S, Patiou P, Hunter AM, Mora E, Geissler K, Dimou M, Jimenez Lorenzo MJ, Melchardt T, Egle A, Viniou AN, Patel BJ, Arnan M, Valent P, Roubakis C, Bernal Del Castillo T, Galanopoulos A, Calabuig Muñoz M, Bonadies N, Medina de Almeida A, Cermak J, Jerez A, Montoro MJ, Cortés A, Avendaño Pita A, Lopez Andrade B, Hellstroem-Lindberg E, Germing U, Sekeres MA, List AF, Symeonidis A, Sanz GF, Larcher-Senn J, Greil R. Pleyer L, et al. Among authors: geissler k. Lancet Haematol. 2021 Feb;8(2):e135-e148. doi: 10.1016/S2352-3026(20)30374-4. Lancet Haematol. 2021. PMID: 33513373
Treatment of de novo acute myelogenous leukemia with recombinant granulocyte macrophage-colony-stimulating factor in combination with standard induction chemotherapy: effect of granulocyte macrophage-colony-stimulating factor on white blood cell counts.
Valent P, Sillaber C, Geissler K, Andreeff M, Tafuri A, Vieder L, Schulz G, Lechner K, Bettelheim P. Valent P, et al. Among authors: geissler k. Med Pediatr Oncol Suppl. 1992;2:18-22. doi: 10.1002/mpo.2950200705. Med Pediatr Oncol Suppl. 1992. PMID: 1306881 Clinical Trial.
Human basophils express interleukin-4 receptors.
Valent P, Besemer J, Kishi K, Di Padova F, Geissler K, Lechner K, Bettelheim P. Valent P, et al. Among authors: geissler k. Blood. 1990 Nov 1;76(9):1734-8. Blood. 1990. PMID: 1699621 Free article.
MDR1 gene expression and treatment outcome in acute myeloid leukemia.
Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L, et al. Pirker R, et al. Among authors: geissler k. J Natl Cancer Inst. 1991 May 15;83(10):708-12. doi: 10.1093/jnci/83.10.708. J Natl Cancer Inst. 1991. PMID: 2023272
Why clinicians should be interested in interleukin-3.
Valent P, Geissler K, Sillaber C, Lechner K, Bettelheim P. Valent P, et al. Among authors: geissler k. Blut. 1990 Dec;61(6):338-45. doi: 10.1007/BF01738546. Blut. 1990. PMID: 2291980 Review.
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
Sperr WR, Walchshofer S, Horny HP, Födinger M, Simonitsch I, Fritsche-Polanz R, Schwarzinger I, Tschachler E, Sillaber C, Hagen W, Geissler K, Chott A, Lechner K, Valent P. Sperr WR, et al. Among authors: geissler k. Br J Haematol. 1998 Dec;103(3):740-9. doi: 10.1046/j.1365-2141.1998.01072.x. Br J Haematol. 1998. PMID: 9858225 Free article.
441 results